{"entity":{"id":"nct06807437","kind":"trial","name":"Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula","aka":[],"tldr":"A phase 3 trial of somatostatin analogues (octreotide, lanreotide) in pancreatic cancer, run by SWOG Cancer Research Network, now recruiting.","summary":"Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula is a phase 3, randomised interventional study registered as NCT06807437 by SWOG Cancer Research Network, with a registry enrolment figure of 274 participants, started 2025-05-09 and due to reach its primary completion in 2027-11-01. Interventions recorded: Biospecimen Collection; Distal Pancreatectomy; Lanreotide; Questionnaire Administration; Saline. Conditions listed: Pancreatic Carcinoma; Pancreatic Neoplasm. Primary outcome: Incidence of postoperative pancreatic fistula (POPF). Pancreatic eligibility wording from the registry: \"* Participants must have histologically or radiographically confirmed diagnosis of pancreatic cancer or a pancreatic lesion with malignant potential\". Sites: United States. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT06807437","url":"https://clinicaltrials.gov/study/NCT06807437"}],"tags":["ctgov-ingest","pancreatic-deep-dive"],"related":[],"cancers":["resectable-pdac"],"sections":[],"technologies":[],"targets":[],"drugs":["octreotide-lanreotide"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06807437","phase":"3","setting":"A Randomized Phase III Blinded Trial of Lanreotide for the Prevention of Postoperative Pancreatic Fistula","sponsor":"SWOG Cancer Research Network","enrolled":274,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06807437/","neighbours":{"cancer":[{"id":"resectable-pdac","kind":"cancer","name":"Resectable pancreatic ductal adenocarcinoma","route":"/cancers/resectable-pdac/"}],"drug":[{"id":"octreotide-lanreotide","kind":"drug","name":"Somatostatin analogues (octreotide, lanreotide)","route":"/drugs/octreotide-lanreotide/"}],"term":[{"id":"pancreatic-trials-open-today","kind":"term","name":"Pancreatic cancer trials open today (registry snapshot and UK sites)","route":"/terms/pancreatic-trials-open-today/"}]}}